FI4488U1 - Farmaseuttinen koostumus - Google Patents

Farmaseuttinen koostumus

Info

Publication number
FI4488U1
FI4488U1 FI990494U FIU990494U FI4488U1 FI 4488 U1 FI4488 U1 FI 4488U1 FI 990494 U FI990494 U FI 990494U FI U990494 U FIU990494 U FI U990494U FI 4488 U1 FI4488 U1 FI 4488U1
Authority
FI
Finland
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
FI990494U
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Inventor
David Philip Elder
Ahmad Al-Ghazawi
Padma Meneaud
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9914601.1A external-priority patent/GB9914601D0/en
Priority claimed from GBGB9914709.2A external-priority patent/GB9914709D0/en
Priority claimed from GBGB9927501.8A external-priority patent/GB9927501D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of FIU990494U0 publication Critical patent/FIU990494U0/fi
Application granted granted Critical
Publication of FI4488U1 publication Critical patent/FI4488U1/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI990494U 1999-06-22 1999-12-03 Farmaseuttinen koostumus FI4488U1 (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9914601.1A GB9914601D0 (en) 1999-06-22 1999-06-22 Composition
GBGB9914709.2A GB9914709D0 (en) 1999-06-23 1999-06-23 Composition
GBGB9927501.8A GB9927501D0 (en) 1999-11-19 1999-11-19 Composition

Publications (2)

Publication Number Publication Date
FIU990494U0 FIU990494U0 (fi) 1999-12-03
FI4488U1 true FI4488U1 (fi) 2000-07-20

Family

ID=27269749

Family Applications (2)

Application Number Title Priority Date Filing Date
FI990494U FI4488U1 (fi) 1999-06-22 1999-12-03 Farmaseuttinen koostumus
FI992609A FI19992609A (fi) 1999-06-22 1999-12-03 Uusi koostumus

Family Applications After (1)

Application Number Title Priority Date Filing Date
FI992609A FI19992609A (fi) 1999-06-22 1999-12-03 Uusi koostumus

Country Status (21)

Country Link
EP (1) EP1064936A1 (fr)
AT (1) AT3722U1 (fr)
AU (2) AU1573100A (fr)
BE (2) BE1013166A6 (fr)
CA (1) CA2291542A1 (fr)
CH (1) CH690024A5 (fr)
DE (2) DE19958228A1 (fr)
DK (2) DK199900435U3 (fr)
ES (1) ES2159260B1 (fr)
FI (2) FI4488U1 (fr)
FR (1) FR2795327A1 (fr)
GB (1) GB2351233A (fr)
GR (1) GR1003490B (fr)
IE (2) IES991108A2 (fr)
IT (1) ITMI992549A1 (fr)
LU (1) LU90483B1 (fr)
NL (2) NL1013750C1 (fr)
NO (1) NO995945L (fr)
PT (1) PT102384A (fr)
SE (1) SE9904404L (fr)
WO (1) WO2000078291A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
GB0003232D0 (en) * 2000-02-11 2000-04-05 Smithkline Beecham Plc Novel composition
AU2001296084A1 (en) * 2000-08-28 2002-03-13 Synthon B.V. Paroxetine compositions and processes for making the same
US6921839B2 (en) 2000-08-29 2005-07-26 Ranbaxy Laboratories Limited Synthesis of N,N-dimethyl-3-(4-methyl) benzoyl propionamide a key intermediate of zolpidem
DE20100529U1 (de) * 2001-01-11 2001-05-10 Synthon Bv Pharmazeutische Tablette umfassend Paroxetinmesylat
CA2361882A1 (fr) * 2001-10-19 2003-04-19 Bernard Charles Sherman Liquide pour administration orale contenant de la paroxetine
JP2005517690A (ja) 2002-02-01 2005-06-16 ファイザー・プロダクツ・インク 固体薬物分散物を含有する即時放出剤形
EP1660496A1 (fr) * 2003-07-31 2006-05-31 Ranbaxy Laboratories Limited Procede pour la synthese de zolpidem
US20080033050A1 (en) 2006-08-04 2008-02-07 Richards Patricia Allison Tewe Method of treating thermoregulatory disfunction with paroxetine
CN105963273A (zh) * 2016-05-02 2016-09-28 杭州富阳伟文环保科技有限公司 甲磺酸帕罗西汀胶囊及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2096853A1 (fr) * 1990-11-24 1992-05-25 Anthony Michael Johnson Emploi de la paroxetine pour le traitement de la demence senile, de la boulimie, de la migraine ou de l'anorexie
GB9514842D0 (en) * 1995-07-20 1995-09-20 Smithkline Beecham Plc Novel formulation
GB9605828D0 (en) * 1996-03-20 1996-05-22 Smithkline Beecham Plc Treatment method
EE03970B1 (et) * 1997-06-10 2003-02-17 Synthon B.V. 4-fenüülpiperidiinühend, selle valmistamine ja kasutamine ning seda sisaldav ravim
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.

Also Published As

Publication number Publication date
AU727000B3 (en) 2000-11-30
WO2000078291A1 (fr) 2000-12-28
DE19958228A1 (de) 2000-12-28
ES2159260B1 (es) 2002-05-01
ITMI992549A1 (it) 2001-06-03
CH690024A5 (fr) 2000-03-31
DK199901730A (da) 2000-12-23
GB2351233A (en) 2000-12-27
LU90483B1 (fr) 2001-01-31
NO995945L (no) 2000-12-27
SE9904404L (sv) 2000-12-23
FIU990494U0 (fi) 1999-12-03
ITMI992549A0 (it) 1999-12-03
EP1064936A1 (fr) 2001-01-03
GB9928673D0 (en) 2000-02-02
GR1003490B (el) 2000-11-30
AU1573100A (en) 2001-01-09
DK199900435U3 (da) 2000-02-11
ES2159260A1 (es) 2001-09-16
IE991107A1 (en) 2001-05-30
BE1012806A3 (fr) 2001-03-06
NL1013749C2 (nl) 2001-01-08
IES991108A2 (en) 2001-04-04
SE9904404D0 (sv) 1999-12-03
FI19992609A (fi) 2000-12-22
NO995945D0 (no) 1999-12-03
BE1013166A6 (fr) 2001-10-02
DE29921300U1 (de) 2000-02-10
FR2795327A1 (fr) 2000-12-29
NL1013750C1 (nl) 2000-12-28
PT102384A (pt) 2000-12-29
AT3722U1 (de) 2000-07-25
CA2291542A1 (fr) 2000-12-22

Similar Documents

Publication Publication Date Title
NO20015175D0 (no) Farmasöytisk sammensetning
PT1242087E (pt) Composicoes farmaceuticas
FI991485A (fi) Uusi farmaseuttinen koostumus
ID27415A (id) Komposisi farmaseutik
DK1524266T3 (da) Farmaceutisk sammensætning
EA199900373A3 (ru) Фармацевтические композиции
ATE392890T1 (de) Hydrogel-gesteuerte dosierungsform
ID29262A (id) Komposisi farmasi
ATE295081T1 (de) Hilfsstoff-zusammensetzung
NO20015670D0 (no) Forbedrede farmasöytiske formuleringer
ID27201A (id) Komposisi farmasi
NO20022606L (no) Farmasöytiske kombinasjoner
DE69943245D1 (de) Gaserzeugende zusammensetzung
PT1239832E (pt) Composicoes farmaceuticas
NO20014926L (no) Farmasöytiske forbindelser
PT1227817E (pt) Composicao farmaceutica aquosa contendo ciclesonida
FI4488U1 (fi) Farmaseuttinen koostumus
DE60020682D1 (de) Resorcinenthaltende zusammensetzung
AR025867A1 (es) Formulacion portasdora farmaceutica
EE200100697A (et) Farmatseutiline kompleks
ID26215A (id) Komposisi farmasi
ID27329A (id) Komposisi penghambat
NO20022845D0 (no) Limsammensetning
SE9800330D0 (sv) Pharmaceutical compositions
FI981567A0 (fi) Farmaseuttiset koostumukset